Home >
News >
#ESHCML2023 ONLY 1 MONTH LEFT TO SUBMIT YOUR ABSTRACT!
#ESHCML2023 ONLY 1 MONTH LEFT TO SUBMIT YOUR ABSTRACT!
April 11, 2023
25th ANNUAL JOHN GOLDMAN CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
BIOLOGY AND THERAPY
October 6-8, 2023
Mandelieu-La Napoule, France - #ESHCML2023
Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa
Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Danilo Perrotti, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten
REMINDER:
DON’T DELAY, SUBMIT YOUR ABSTRACT NOW!
DEADLINE COMING UP!
DEADLINE FOR ABSTRACTS
FOR ORAL AND POSTER PRESENTATIONS:
MAY 8th, 2023 (23:59 CEST)
LEUKAEMIA UK INTERNATIONAL SCHOLARSHIPS
This Call for Applications is made thanks to funding support from:
The present Call for Applications may be of interest to you if you are:
- Fully trained, with a maximum of 4 years experience since your first junior faculty appointment
- A Resident or PhD candidate
Deadline for applications: May 8th, 2023
Six early-career biologists and clinicians attended
the 2022 John Goldman Conference on CML
thanks to support from Leukaemia UK
The ESH Scholarship Fund is a multi-sponsored project designed to support access to new biological and clinical data in the context of lifelong learning in Haematology.
- ESH independently ensures all scientific peer review and selection procedures.
- ESH is also independently responsible for all administrative aspects of the Fund.
Stay tuned for announcements regarding other ESH Scholarship Fund Scholarships.
ABOUT THE CONFERENCE
The program includes the latest in research in chronic myeloid leukemia, including basic, translational and clinical research with an emphasis on open discussion among participants. There are also scientific workshops to discuss the latest technologies of value in CML research, and clinical symposia with focus on topics of interest to the CML community. There are special lectures on topics of general interest to the CML community from lead experts in their field. The program is designed to encourage discussion and collaboration among participants, presenters and attendees.
The program will be of interest to:
- Junior and senior biologists and clinicians (MD, PhD, MD-PhD)
- Residents and biologists still in-training
- Physicians and other healthcare providers managing patients with CML
- Researchers with interest in hematologic malignancies and myeloproliferative neoplasms in general,
and CML in particular
MORE INFORMATION
